Anti-PCSK9 and methods for treating lipid and cholesterol disorders

Details for Australian Patent Application No. 2008316587 (hide)

Owner SCHERING CORPORATION

Inventors Hedrick, Joseph A.; Monsma Jr., Frederick James; Hollenbaugh, Diane; Churakova, Tatyana

Agent Griffith Hack

Pub. Number AU-A-2008316587

PCT Pub. Number WO2009/055783

Priority 60/982,922 26.10.07 US

Filing date 27 October 2008

Wipo publication date 30 April 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/055783 Priority application(s): WO2009/055783

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008316597-System and method for anaerobic digestion of biomasses

2008316577-Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof